Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug 1;53(4):170-176.
doi: 10.1097/JNN.0000000000000596.

Depression and Anxiety Management in Parkinson Disease

Haily Ho, Isabel Jose, Molly Cheesman, Christina Garrison, Krista Bishop, Samantha Taber, Jennifer Witt, Mo-Kyung Sin

Depression and Anxiety Management in Parkinson Disease

Haily Ho et al. J Neurosci Nurs. .

Abstract

BACKGROUND: Depression and anxiety are common but underrecognized and undertreated nonmotor symptoms of Parkinson disease (PD) due to their diagnostic criteria overlapping with other PD symptoms, limited randomized controlled studies in this specific population, and the need for multidisciplinary expertise. The purpose of this article is to offer evidence-based solutions for managing comorbid depression and anxiety in patients with PD through a case study analysis. CASE STUDY: A case study is used to illustrate the somatic manifestations of anxiety in PD that leads to diagnostic challenge and multidisciplinary management. MANAGEMENT CONSIDERATIONS: The appropriate use of screening tools, pharmacological and nonpharmacological management, and education are important interventions to consider when treating depression and anxiety in PD. CONCLUSION: Effective management requires accurate assessments, individualized treatment modalities, and patient education. Nurses who are knowledgeable about the effects and management of mood disorders in PD can play an integral role in the multidisciplinary team approach for assessment, patient and caregiver education, and treatment plan implementation.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

References

    1. Compta Y, Revesz T. Neuropathological and biomarker findings in Parkinson's disease and Alzheimer's disease: from protein aggregates to synaptic dysfunction. J Parkinsons Dis . 2020;11:107–121. https://doi.org/10.3233/JPD-202323 - DOI
    1. DeMaagd G, Philip A. Parkinson's disease and its management: part 1: disease entity, risk factors, pathophysiology, clinical presentation, and diagnosis. P T . 2015;40(8):504–532.
    1. Marsh L. Depression and Parkinson's disease: current knowledge. Curr Neurol Neurosci Rep . 2013;13(12):409.
    1. Grover S, Somaiya M, Kumar S, Avasthi A. Psychiatric aspects of Parkinson's disease. J Neurosci Rural Pract . 2015;6(1):65–76.
    1. Chuquilín-Arista F, Álvarez-Avellón T, Menéndez-González M. Prevalence of depression and anxiety in Parkinson disease and impact on quality of life: a community-based study in Spain. J Geriatr Psychiatry Neurol . 2020;33(4):207–213.

LinkOut - more resources